DC
SBIO icon

Davenport & Co’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Davenport & Co’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Hold
11,100
– – ﹤0.01% 876
2026
Q1 		$581K Hold
11,100
– – ﹤0.01% 877
2025
Q4 		$569K Sell
11,100
-474,312
-98% -$21.9M ﹤0.01% 861
2025
Q3 		$18.9M Sell
485,412
-200,225
-29% -$6.88M 0.1% 171
2025
Q2 		$20.8M Sell
685,637
-62,485
-8% -$1.79M 0.11% 155
2025
Q1 		$21.3M Sell
748,122
-21,349
-3% -$675K 0.12% 152
2024
Q4 		$25.4M Sell
769,471
-291
-0% -$11K 0.14% 140
2024
Q3 		$28.7M Sell
769,762
-1,138
-0.1% -$41.5K 0.16% 132
2024
Q2 		$25.7M Sell
770,900
-289
-0% -$9.68K 0.16% 136
2024
Q1 		$27.5M Buy
771,189
+83,403
+12% +$2.89M 0.17% 136
2023
Q4 		$22.7M Sell
687,786
-125
-0% -$3.36K 0.15% 134
2023
Q3 		$18.7M Sell
687,911
-3,242
-0.5% -$97.6K 0.14% 137
2023
Q2 		$21.8M Buy
691,153
+2,137
+0.3% +$66.4K 0.16% 131
2023
Q1 		$18.7M Buy
689,016
+77,616
+13% +$2.34M 0.15% 138
2022
Q4 		$18.5M Buy
+611,400
New +$18.4M 0.15% 136
2015
Q4 		– Sell
-42,587
Closed -$1.19M – 607
2015
Q3 		$1.19M Buy
+42,587
New +$1.49M 0.02% 248

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Davenport & Co's SBIO Position: Q2 2026 in Review

Davenport & Co held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 11,100 shares worth $718K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Davenport & Co first reported a position in SBIO in Q3 2015 and has held it in 16 quarters since. The position peaked at $28.7M in Q3 2024. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Davenport & Co held 11,100 shares of ALPS Medical Breakthroughs ETF worth $718K as of Q2 2026.
  • Davenport & Co left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #876 holding.
  • Davenport & Co first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and has held it in 16 quarters since.
  • Davenport & Co's ALPS Medical Breakthroughs ETF position peaked at $28.7M in Q3 2024.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.